
    
      Trametinib is a drug that works by binding to and blocking certain proteins called
      mitogen-activated protein kinase kinase (MEK) 1 and MEK2 from working. MEK1 and MEK2 are
      important proteins that contribute to the growth of cancer cells.

      GSK2256098 is a drug that blocks a protein called focal adhesion kinase-1 (FAK) which is an
      important protein that contribute to the growth of cancer cells.
    
  